Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis
J. Huang (Dundee (Angus), United Kingdom), E. Kuzmanova (Dundee (Angus), United Kingdom), A. Dicker (Dundee (Angus), United Kingdom), H. Keir (Dundee (Angus), United Kingdom), S. Finch (Dundee (Angus), United Kingdom), S. Aliberti (MIlan, Italy), T. Fardon (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom)
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Session: New biomarkers for management of obstructive diseases
Session type: Oral Presentation
Number: 4718
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Huang (Dundee (Angus), United Kingdom), E. Kuzmanova (Dundee (Angus), United Kingdom), A. Dicker (Dundee (Angus), United Kingdom), H. Keir (Dundee (Angus), United Kingdom), S. Finch (Dundee (Angus), United Kingdom), S. Aliberti (MIlan, Italy), T. Fardon (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom). Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis. 4718
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: